Unknown

Dataset Information

Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy.


ABSTRACT:

Importance

Immune-related adverse events (irAEs) due to immune checkpoint blockade (ICB) have been shown to be positively associated with survival. Among patients with metastatic melanoma, evidence supporting this association has been conflicting, while ipilimumab-nivolumab combination ICB has been examined only in small clinical cohorts.

Objective

To examine the association between irAEs and survival among patients with metastatic melanoma, in particular for those receiving combination ICB.

Design, setting, and participants

A retrospective cohort of 492 consecutive patients with metastatic melanoma treated with ICB at 2 tertiary and 4 regional cancer centers in Alberta, Canada, from August 1, 2013, to May 31, 2020, was observed. Patients were aged 18 years or older w

SUBMITTER: Watson AS 

PROVIDER: S-EPMC9856439 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature